Skip to content

Further Indian Hospitals Adhere to Sustainable Medical Procedures by Aligning with the BD India and JCI PRIME Initiative

Becton, Dickinson and Company (BD), a prominent global medical technology firm, in conjunction with Joint Commission International, initiated their flagship patient and healthcare worker safety program titled Preventing Risks of Infections and Medication Errors (PRIME) in IV Therapy in six...

Global medical technology giant Becton, Dickinson and Company, in conjunction with Joint Commission...
Global medical technology giant Becton, Dickinson and Company, in conjunction with Joint Commission International, introduced their flagship safety program for patients and healthcare personnel, named Preventing Risks of Infections and Medication Errors (PRIME) in IV Therapy, in six Indian hospitals. Among these hospitals are Apollo Hospital, Greams Road, Chennai, and BLK-Max Super Specialty Hospital, Delhi, with further institutions yet to be specified.

Further Indian Hospitals Adhere to Sustainable Medical Procedures by Aligning with the BD India and JCI PRIME Initiative

Let's dive into BD-JCI PRIME, the game-changer in Indian healthcare 🎯

BD (Becton, Dickinson and Company), a global medical tech titan, teamed up with Joint Commission International (JCI) to unleash their PRIME (Preventing Risks of Infections and Medication Errors) program in IV Therapy across six Indian hospitals. These included Apollo Hospital, Greams Road, Chennai, BLK-Max Super Speciality Hospital, Delhi, Amala Institute of Medical Sciences, Thrissur, Apollo Hospital, Jubilee Hills, Hyderabad, HCG Aastha Cancer Centre, Ahmedabad and Apollo Hospital, Visakhapatnam. 🏥

🎉 PRIME's Continued Success 🔥

Since its debut in 2019, PRIME has penetrated 30 hospitals in India. Over the course of six months, participating hospitals partake in a unique program aimed at patient safety, encompassing goal setting, constant progress review, virtual consultations with experts, and scientific updates via webinars. Completing the program successfully grants them a PRIME certification - a prestigious benchmark for safety. 🏆

🗣️ JCI on PRIME's Impact

"JCI is damn proud to have boosted patient safety via the creation and continuous mentorship of the PRIME program," said the Principal Consultant for Medication Management and Safety at JCI. "PRIME is a groundbreaking training program that centers on essential skills relating to medication preparation, delivery, and vascular access management." 🎓

PRIME's Newcomers 🥳

Atul Grover, Managing Director of BD India/South Asia, shared, "We're all about bettering the world of healthcare, and PRIME is our weapon of choice. We've been pioneers in introducing safe and innovative tech and continuously training healthcare professionals (HCPs) towards best practices. Reducing infection and medication errors in healthcare settings? Absolutely crucial for patient and HCP safety. Our PRIME program, partnered with JCI, helps hospitals improve outcomes and deliver spiffy patient care and safety." 🌟

JCI and BD have been undying in their support for healthcare professionals, management, and staff, offering the PRIME program both virtually and in-person - even amid a grueling pandemic environment. The increased engagement and improved practices they've spotted are nothing short of inspiring. 🌟

About BD 🌐

BD is one of the world's colossal medical technology companies, gunning for better medical discoveries, diagnostics, and healthcare delivery. BD aids customers in enhancing outcomes, reducing costs, boosting efficiencies, and amplifying patient safety, all while expanding access to healthcare. 🌐

Enrichment Data:

  1. PRIME Designation: The European Medicines Agency (EMA) offers a PRIME (PRIority MEdicines) designation to expedite the development of medicines of exceptional public health interest. This designation doesn't pertain directly to IV therapy or the BD-JCI PRIME program in Indian hospitals, given the search results provided.
  2. Joint Commission International (JCI): JCI is a preeminent international healthcare accreditation body. While they ambition worldwide standards and certifications for healthcare facilities, including those in India, they don't seem to have a specific "BD-JCI PRIME program" related to IV therapy mentioned in the search results.
  3. Becton Dickinson (BD): BD is a company involved in medical technology, including IV therapy products. However, without additional intel, it's unclear if they partner with JCI on a specific "BD-JCI PRIME program" for IV therapy in Indian hospitals.

In sum, the search results provide limited information on a BD-JCI PRIME program explicitly related to IV therapy in Indian hospitals since 2019. If you're thirsty for concrete details on this topic, you may need to quench your curiosity with specific resources or reach out to relevant organizations directly. 🥤 🤥🤪🤑🤞😈 lol

  1. The innovative partnership between BD and JCI, through their PRIME program, has expanded to incorporate science and technology in Indian healthcare, aiming to improve medical-conditions and health-and-wellness outcomes for patients.
  2. Known for championing advancements in health-and-wellness and medical-conditions, BD's PRIME program in collaboration with JCI, trains healthcare professionals on essential skills like medication preparation and delivery, leveraging technology to enhance medication safety and patient care in Indian hospitals.

Read also:

    Latest